http://rdf.ncbi.nlm.nih.gov/pubchem/patent/AR-070075-A1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0a9e6421e9257148abad101e1ce6c162 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P17-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P17-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D471-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P19-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07F7-2208 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P19-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P19-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-24 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-30 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-28 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00 |
| filingDate | 2008-12-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0447ca2e67e2c48c163b3bae4f00ea04 |
| publicationDate | 2010-03-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | AR-070075-A1 |
| titleOfInvention | DERIVATIVES OF N- HETEROCICLICO -6- HETEROCICLICO IMIDAZO (1,2- ALFA) PIRIDINA -2- CARBOXAMIDS, PHARMACEUTICAL COMPOSITION, A MEDICINAL PRODUCT THAT INCLUDES THE COMPOUND AND USE OF THE COMPOUND FOR THE PREPARATION OF A MEDICINAL PRODUCT |
| abstract | These compounds are useful in neurodegenerative diseases, psychiatric diseases, inflammatory and autoimmune diseases such as osteoarthritis, allergies, asthma and osteoporosis. Claim 1: Compounds that respond to formula (1) in which X represents a heterocyclic group optionally substituted with one or more groups independently selected from each other from the following atoms or groups: halogen, C1-6 alkoxy, C1 alkyl -6, NRaRb, cyano, oxide, COOR8, the alkyl and alkoxy groups being optionally substituted with one or more halogen atoms; R1 represents a hydrogen atom, a halogen atom, a C1-6 alkoxy group, C2-6 alkyl, amino or NRaRb; the alkyl and alkoxy groups may be optionally substituted with one or more halogen atoms, a hydroxy, amino or C1-6 alkoxy group; R2 represents a heterocyclic group, this group being optionally substituted with one or more groups independently selected from each other among the following atoms or groups: hydroxy, C1-6 alkyl, C1-6 alkoxy, halogen, cyano, NRaRb, -CO- R5, -CO-NR6R7, -CO-O-R8, -NR9-CO-R10, the C1-6 alkyl and C1-6 alkoxy groups being optionally substituted with one or more halogen atoms or hydroxy groups, NRaRb, oxide; R3 represents a hydrogen atom, a C1-6 alkyl group, C1-6 alkoxy or a halogen atom; R4 represents a hydrogen atom, a C1-4 alkyl group, C1-4 alkoxy or a fluorine atom; R5 represents a hydrogen atom, a phenyl group or a C1-6 alkyl group; R4 and R7, identical or different, represent a hydrogen atom or a C1-6 alkyl group or form with the nitrogen atom which takes a cycle of 4 to 7 links optionally including another heteroatom selected from N, O or S; R8 represents a C1-6 alkyl group; R9 and R10, identical or different, represent a hydrogen atom or a C1-6 alkyl group; Ra and Rb independently represent each other, a hydrogen atom, a C1-6 alkyl group or form with the nitrogen atom to which a cycle of 4 to 7 links are attached, which optionally includes another heteroatom chosen from N, O or S; in the form of base or salt of acid addition. |
| priorityDate | 2008-01-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 45.